Head Portfolio, International Region

100% revenue growth, that is our ambition in International Region for the next 5 years With more than 3,000 associates serving patients across 4 continents and 19 time zones we have a truly global impact and unlimited opportunities to help people around the world access high-quality medicine. Sandoz, a division of Novartis, is a global leader in Generic and Biosimilar medicines.
- Job Purpose:

- The Head Portfolio, International Region leads product portfolio development across the Region, by identifying and driving strategic portfolio choices, pipeline projects prioritization and successful execution of product pipeline in line with Global and Regional growth strategy. Develops and implements best in class Portfolio selection and execution practices across the Region and cross-functionally.
- Key Responsibilities:
- Drive increase in value of new product pipeline across International Region by identifying and selecting high-value strategic assets, ensuring high-quality evaluation, timely allocation to execution and successful progression of selected pipeline assets through all pipeline execution phases from selection to launch.
- Develop mid
- (next 3-5 years) and long-term (5-10 years) portfolio strategy with a detailed product / country portfolio execution plan.
- Maintain and regularly share with direct manager and other relevant functions an in-depth market intelligence for key markets of the Region with clarity regarding market archetype, regulatory aspects, commercial infrastructure as well as relevant customer insights to facilitate high-quality assessments and decision-making;
- Implement and foster culture of in-depth assessments and consistent methodology for portfolio evaluations within the Regional Portfolio and across country Portfolio teams - ensuring portfolio choices are based on in-depth evaluations, key value drivers are identified and aligned to market specifics and customer insights, key assumptions are validated, aligned with relevant stakeholders and well-documented, ensuring consistency in portfolio choices and efficient resource allocation.
- Establish robust consistent methodology to evaluate, develop recommendations and define most efficient project execution route - allocation to in-house development (PD) or external partnerships (BD) - maximizing pipeline value, probability to launch successfully and availability of critical resources.
- Monitor and facilitate efficient progress of projects in execution and timely escalation to relevant stakeholders to ensure pipeline value maximization.
- Close alignment with relevant country, Regional and Global functions, including Commercial, Portfolio, BD, Launch Management, Regulatory, Project Management, IP, Legal and other functions to ensure their continued support in Regional Portfolio strategy execution;
- Ensure continued team development, increase in productivity and engagement within the Regional Portfolio team and country Portfolio teams by prioritizing learning and development initiatives, fostering engagement and culture of personal growth, acquisition of new skills, pro-active best practice sharing and accelerating innovation

**Commitment to Diversity & Inclusion**:

- Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve._

**Minimum requirements**
- What you'll bring to the role:
- MSc, MBA or PhD with background in Finance, Economics, Management, Business Administration or Life Sciences.
- 7+ years’ experience in management consulting or pharmaceutical portfolio management.
- 5+years’ experience in leading and building high performing teams.
- Strong financial modelling and valuations skills and in-depth understanding of main financial valuation methods.
- Proven ability to drive and execute global projects in various geographies including one or more of the following countries; Japan, Australia, China, Brazil, Mexico, South Africa,
- Fluency in English - required; Spanish, Portuguese or Japanese - desirable.

Why Sandoz?
- 500 million patients were touched by Sandoz generic and biosimilar medicines in 2021 and while we’re proud of this, we know there is more we could do to continue to help pioneer access to medicines for people around the world.
- How will we do this? We believe new insights, perspectives and ground-breaking solutions can be found at the intersection of medical science and digital innovation. That a diverse, equitable and inclusive environment inspires new ways of working.
- We believe our potential can thrive and grow in an unbossed culture underpinned by integrity, curiosity and flexibility. And we can reinvent what's possible, when we collaborate with courage to aggressively and ambitiously tackle the world’s toughest medical challenges. Because the greatest risk in life, is the risk of never trying
- Imagine what you could do here at Sandoz

**Division**
- SANDOZ

**Business Unit**
- Commercial